Prostate Cancer News and reporting on prostate cancer. Angle Readies for Clinical Testing as CTC Research Continues to Yield Biomarker Insights Premium The company is embarking on its own diagnostic plans as it prepares to market its platform for external test development following FDA clearance. Caris Life Sciences, Essa Pharma Ink Liquid Biopsy Partnership for Prostate Cancer Trial Essa will use Caris' blood-based sequencing tests to assess the genetic profiles of mCRPC patients enrolled in a Phase I trial of the firm's investigational agent. Polygenic Risk Scores for Breast, Prostate Cancer Adaptable for Cross-Ancestry Use, Study Shows The researchers said the approach could be a short-term measure while genetic studies of more diverse ancestral populations are performed. MDxHealth H1 2021 Revenues Up 9 Percent As Testing Volumes Rebound The firm saw volume growth of 4 percent for its ConfirmMDx prostate cancer test and 9 percent for its SelectMDx test. Burning Rock Biotech, Impact Therapeutics Partner on CDx for PARP Inhibitor Senaparib The NGS firm will work with Impact to develop companion diagnostics to select patients eligible for Impact's synthetic lethality drugs, beginning with senaparib. Sep 19, 2017 Exosome Diagnostics Launches Evidence Development Study for Prostate Cancer Test Sep 15, 2017 University of Michigan Researchers Develop New Microfluidic Device to Track Cancer Premium Sep 12, 2017 NorthShore Enlists Ambry Genetics for Whole-Exome Sequencing Sep 11, 2017 Qiagen, Angle to Comarket Liquid Biopsy Technologies Aug 31, 2017 MDxHealth H1 Revenues Up 87 Percent Aug 24, 2017 Palmetto Finalizes LCD Expanding Coverage for Genomic Health Prostate Cancer Test Aug 7, 2017 Regulatory Features of Fusion-Containing Prostate Tumors Hint at Potential Treatment Strategy Aug 3, 2017 Color Genomics Maps New Customer Inroads With Cancer Dx Testing Partnerships Premium Aug 1, 2017 Genomic Health Q2 Revenues Up 4 Percent, Miss Wall Street Expectations Jul 27, 2017 OTraces Plans Early Cancer Diagnostics Based on Signal-Enhanced Protein Markers Premium Jul 14, 2017 Technical Advances Position MALDI Imaging as Plausible Tool for Clinical Pathology Premium Jul 13, 2017 Berg, DoD Using AI Platform to Ready Diagnostic Test for Prostate Cancer Premium Jul 13, 2017 MDx Health Launches Bladder Cancer Test, Hoping Relationships in Urology Market Will Hasten Uptake Premium Jul 12, 2017 Asia Genomics, CellMax Partner on Cancer Dx in Southeast Asia Jul 10, 2017 MDxHealth Signs Middle East Distribution Deal for Prostate Cancer Test Jun 30, 2017 Prostate Cancers From African Americans Show Splice Variants Implicated in Tumor Invasiveness Jun 29, 2017 GenomeDx Prostate Cancer Tests Get New York State Approval Jun 27, 2017 Prostate Cancer Recurrence Signatures Proposed From MicroRNA Meta-Analysis Jun 23, 2017 Liquid Biopsy May Guide PARP Inhibitor Therapy for Prostate Cancer Premium Jun 20, 2017 VA Collaborates With DOE on Supercomputing for Million Veteran Analytics Premium Load More Breaking News In Brief This Week: Veracyte, Danaher, Chembio Diagnostics, and More Decode Genetics Plasma Proteome Study Improves Understanding of Disease Pathogenesis Euformatics Gains CE-IVD Mark for OmnomicsNGS People in the News: New Appointments at SomaLogic, 23andMe, Pacific Biosciences, More New Products Posted to GenomeWeb: GenDx, Eurofins Technologies, Codex DNA, More Variant Identified in Amish Population Appears to Protect From Cardiovascular Disease The Scan Steps for Quick Review The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal. Moving Away From Using Term 'Race' A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports. Point of the Program The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question. Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.